Skip to main content
. 2019 Jan 1;10(3):749–756. doi: 10.7150/jca.28099

Figure 3.

Figure 3

Clinical significance of FOXM1 alterations in patients with PCa in published datasets. (A) The OncoPrint of genetic alterations of FOXM1, including amplifications, deep deletions, mRNA upregulation, truncation mutations, and missense mutations, are shown in PCa using cBioPortal. Only representative cases are shown. (B, C) Kaplan-Meier analysis of overall survival and disease-free survival is shown from TCGA data from cBioPortal.